The Research Progress of Basal-like Breast Carcinoma
1 Department of Breast Surgery, the Second Affiliated of Harbin Medical University, Harbin, Heilongjiang, China
2 Heilongjiang Academy of Medical Sciences, Harbin, Heilongjiang, 150081, China
Cancer Genetics and Epigenetics, 2018, Vol. 6, No. 3 doi: 10.5376/cge.2018.06.0003
Received: 10 Aug., 2018 Accepted: 20 Sep., 2018 Published: 26 Oct., 2018
© 2018 BioPublisher Publishing Platform
This is an open access article published under the terms of the Creative Commons Attribution License
, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Preferred citation for this article:
Zhang J.Y., and Zhang D.W., 2018, The research progress of basal-like breast carcinoma, Cancer Genetics and Epigenetics, 6(3): 19-25 (doi: 10.5376/cge.2018.06.0003)
Basal-like breast carcinoma is a heterogeneous disease of high malignancy and poor prognosis, which is subordinate to breast carcinoma with high recurrence rate and distinctive route of metastasis. Comparing with osseous metastasis, basal-like breast carcinoma has more feasibility of metastasis to viscera. Chemotherapy is the only effectively therapy of basal-like breast carcinoma. Looking for the marker of basal-like breast carcinoma is supposed to be the tendency of the treatment of the disease.
Basal-like breast carcinoma; Triple negative breast carcinoma; Targeted therapy
Cancer Genetics and Epigenetics
• Volume 6